Article Details

Reassessing COVID-19 Treatments: Nirmatrelvir/Ritonavir and Molnupiravir Against New Variants

Retrieved on: 2024-09-19 18:41:05

Tags for this article:

Click the tags to see associated articles and topics

Reassessing COVID-19 Treatments: Nirmatrelvir/Ritonavir and Molnupiravir Against New Variants. View article details on hiswai:

Excerpt

Long-term follow-up data were available for 23,008 participants (89.2%), with most having received at least one dose of a SARS-CoV-2 vaccine. 2.

Article found on: www.contagionlive.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo